Inhibition of Serotonin Metabolic Enzyme UDP-Glucuronosyltransferases (UGT) 1A6 by Ochratoxins

被引:0
|
作者
Yuan, Yang [1 ]
Du, Peng [1 ]
Yang, Shumei [2 ]
机构
[1] Xinjiang Med Univ, Affiliated Hosp 2, Dept Neurosurg, Urumqi 830028, Peoples R China
[2] Xinjiang Med Univ, Affiliated Hosp 5, Dept Pharmaceut Preparat, Urumqi 830011, Peoples R China
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2017年 / 36卷 / 02期
关键词
enzyme inhibition; ochratoxins; serotonin; toxicity; UDP-glucuronosyltransferase (UGT) 1A6;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The exposure of human to ochratoxins is unavoidable, and toxicity of ochratoxins remains to severely threaten the health of human. The present study aims to investigate the influence of ochratoxins on the activity of important phase II drug-metabolizing enzymes (DMEs) UDP-glucuronosyltransferase (UGT) 1A6. The results showed that ochratoxin A and B exerted no influence on the activity of UGT1A6. However, ochratoxin C showed strong inhibition on the activity of UGT1A6. In silico docking study showed that higher binding free energy of ochratoxin C on the activity cavity of UGT1A6 mainly contributed to the stronger inhibition of ochratoxin C than ochratoxin A and B towards the activity of UGT1A6. Inhibition kinetic determination showed the noncompetitive inhibition of ochratoxin C on UGT1A6. The inhibition kinetic parameter (Ki) was calculated to be 2.5 mu M for the inhibition of ochratoxin C on UGT1A6. All these data will be beneficial for understanding the toxicity mechanism of ochratoxins. RESUMEN. La exposicion de los seres humanos a las ocratoxinas es inevitable y la toxicidad de las ocratoxinas sigue siendo una grave amenaza para la salud. El presente estudio tiene como objetivo investigar la influencia de ocratoxinas en la actividad de las enzimas que metabolizan la importante fase II de drogas (DME) UDP-glucuronosyltransferase (UGT) 1A6. Los resultados mostraron que la ocratoxina A y B no ejercen influencia alguna sobre la actividad de UGT1A6. Sin embargo, la ocratoxina C mostro una fuerte inhibicion de la actividad de UGT1A6. Un estudio de acoplamiento in silico mostro que el aumento de la energia libre de union de la ocratoxina C en la cavidad de la actividad de UGT1A6 contribuyo principalmente a la inhibicion mas fuerte de la ocratoxina C que la ocratoxina A y B hacia la actividad de UGT1A6. La cinetica de determinacion de la inhibicion mostro la inhibicion no competitiva de la ocratoxina C en UGT1A6. El parametro cinetico de inhibicion (Ki) se calculo que era 2,5 mu M para la inhibicion de la ocratoxina C en UGT1A6. Todos estos datos seran beneficiosos para la comprension del mecanismo de toxicidad de las ocratoxinas.
引用
收藏
页码:412 / 415
页数:4
相关论文
共 50 条
  • [31] Selectivity for inhibition of nilotinib on the catalytic activity of human UDP-glucuronosyltransferases
    Ai, Limei
    Zhu, Liangliang
    Yang, Lu
    Ge, Guangbo
    Cao, Yunfeng
    Liu, Yong
    Fang, Zhongze
    Zhang, Yanyan
    XENOBIOTICA, 2014, 44 (04) : 320 - 325
  • [32] Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
    Krishnaswamy, S
    Duan, SX
    Von Moltke, LL
    Greenblatt, DJ
    Court, MH
    DRUG METABOLISM AND DISPOSITION, 2003, 31 (01) : 133 - 139
  • [33] Inhibition of UDP-Glucuronosyltransferases (UGTs) Activity by constituents of Schisandra chinensis
    Song, Jin-Hui
    Cui, Li
    An, Li-Bin
    Li, Wen-Tao
    Fang, Zhong-Ze
    Zhang, Yan-Yan
    Dong, Pei-Pei
    Wu, Xue
    Wang, Li-Xuan
    Gonzalez, Frank J.
    Sun, Xiao-Yu
    Zhao, De-Wei
    PHYTOTHERAPY RESEARCH, 2015, 29 (10) : 1658 - 1664
  • [34] Investigation of the Inhibition of UDP-Glucuronosyltransferases (UGTs) by Retinoic Acid and Retinaldehyde
    Sun, Xiao-Yu
    Cao, Yun-Feng
    Fu, Zhi-Wei
    Li, Qing
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (06): : 1142 - 1146
  • [35] New insights for the risk of bisphenol A: Inhibition of UDP-glucuronosyltransferases (UGTs)
    Jiang, Hua-Mao
    Fang, Zhong-Ze
    Cao, Yun-Feng
    Hu, Cui-Min
    Sun, Xiao-Yu
    Hong, Mo
    Yang, Ling
    Ge, Guang-Bo
    Liu, Yong
    Zhang, Yan-Yan
    Dong, Qiang
    Liu, Ren-Jie
    CHEMOSPHERE, 2013, 93 (06) : 1189 - 1193
  • [36] High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human
    Akazawa, Takanori
    Uchida, Yasuo
    Miyauchi, Eisuke
    Tachikawa, Masanori
    Ohtsuki, Sumio
    Terasaki, Tetsuya
    MOLECULAR PHARMACEUTICS, 2018, 15 (01) : 127 - 140
  • [37] Comparison of UDP-glucuronosyltransferases 1A1 (UGT1A1) promoter polymorphism detection methods: a journey into pharmacogenetics
    Holtegaard, L. M.
    Skierka, J.
    Moore, B. E.
    Baudhuin, L. M.
    Highsmith, W. E.
    O'Kane, D. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 627 - 627
  • [38] SUBSTRATE SPECIFICITIES OF 2 STABLY EXPRESSED HUMAN LIVER UDP-GLUCURONOSYLTRANSFERASES OF THE UGT1 GENE FAMILY
    EBNER, T
    BURCHELL, B
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (01) : 50 - 55
  • [39] Expression and regulation of UDP-glucuronosyltransferases from the UGT1A and UGT2B families in mice with altered PXR activity
    Radominska-Pandya, A
    Xie, W
    Heydel, JM
    DRUG METABOLISM REVIEWS, 2003, 35 : 56 - 56
  • [40] Structure-inhibition relationship of ginsenosides towards UDP-glucuronosyltransferases (UGTs)
    Fang, Zhong-Ze
    Cao, Yun-Feng
    Hu, Cui-Min
    Hong, Mo
    Sun, Xiao-Yu
    Ge, Guang-Bo
    Liu, Yong
    Zhang, Yan-Yan
    Yang, Ling
    Sun, Hong-Zhi
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2013, 267 (02) : 149 - 154